Molecular heterogeneity of β-thalassemia in Algeria: How to face up to a major health problem

Hemoglobin

Volumn 33, Issue 1, 2009, Pages 24-36

  Boudrahem Addour, Nassima ^a   Zidani, Nadia ^b   Carion, Nathalie ^c   Labie, Dominique ^d   Belhani, Meriem ^b   Beldjord, Cherif ^c,d,e  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Centre Hospitalier et Universitaire de Beni Messous Algiers   (Algeria)

^c Institut Cochin   (France)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

thalassemia ( thal); Diagnosis strategy; Genetic heterogeneity

Indexed keywords

ADULT; ALGERIA; ALLELE; ARTICLE; BETA THALASSEMIA; CHROMOSOME; CODON; FEMALE; FOUNDER EFFECT; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; POLYADENYLATION; PROMOTER REGION; SOCIAL STATUS;

ALGERIA; ALLELES; BETA-THALASSEMIA; CHROMOSOMES, HUMAN; DNA MUTATIONAL ANALYSIS; EMIGRATION AND IMMIGRATION; FOUNDER EFFECT; GENETIC HETEROGENEITY; HUMANS; MUTATION;

EID: 60749132798     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260802626061     Document Type: Article

References (68)

1. Cao A, Goossens M, Piratsu M. β Thalassaemia mutations in Mediterranean populations. Br J Haematol. 1989;71(3): 309-312.
2. Labie D, Bennani C, Beldjord C. β Thalassemia in Algeria. Ann NY Acad Sci. 1990;612:43-54.
3. Bennani C, Tamouza R, Rouabhi F, et al. The spectrum of β-thalassemia in Algeria: Possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol. 1993;84(2):335-337.
4. Bouhass R, Perrin P, Trabuchet G. The spectrum of β-thalassemia mutations in the Oran region of Algeria. Hemoglobin. 1994;18(3):211-219.
5. Bennani C, Bouhass R, Perrin-Pecontal P, et al. Anthropological approach to the heterogeneity of β-Thalassemia mutations in Northern Africa. Hum Biol. 1994;66(3):369-382.
6. Labie D, Benabadji M, Elion J. Genetic disorders in North African populations of the Maghreb: Morocco, Algeria and Tunisia. In: Teebi AS, Farag TI, eds. Genetic Disorders among Arab Populations. New York: Oxford University Press; 1995:290-321.
7. Colah R, Nadkarni A, Gorakshakar A, et al. Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India. Blood Cells Mol Dis. 2004;33(2):153-157.
8. Miller SA, Dykes DD, Polesky HF. A simple salting out for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988;16(3):1215.
9. Fernandez E, Bienvenu T, Desclaux Arramond F, et al. Use of chemical clamps in denaturing gradient gel electrophoresis: Application in the detection of the most frequent Mediterranean β-thalassemic mutations. PCR Methods Appl. 1993;3(2):122-124.
10. Laradi S, Haj Khellil A, Omri H, et al. Analyse moléculaire et diagnostic prénatal de la β thalassemie: à propos de notre expérience en Tunisie centrale. Ann Biol. 2000;58(4):453-460.
11. Orkin SH, Kazazian HH Jr, Antonarakis SE, et al. Linkage of β thalassaemia mutations and β globin gene polymorphisms with DNA polymorphisms in human β globin gene cluster. Nature. 1982;296(5858):627-631.
12. Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes. Am J Hematol. 1989;32(1):66-69.
13. Fei YJ, Stoming TA, Efremov GD, et al. β Thalassemia due to a T→A mutation within the ATA box. Biochem Biophys Res Commun. 1988;153(2):741-747.
14. Antonarakis SE, Orkin SH, Cheng TC, et al. β-Thalassemia in American Blacks: Novel mutations in the TATA box and IVS-2 acceptor splice site. Proc Natl Acad Sci USA. 1984;81(4):1154-1158.
15. Badens C, Thuret I, Michel G, et al. Novel and unusual deletion-insertion thalassemic mutation in exon 1 of the β globin gene. Hum Mutat. 1996;8(1):89-92.
16. Orkin SH, Antonarakis SE, Loukopoulos D. Abnormal processing of β Knossos RNA. Blood. 1984;64(1):311-313.
17. Chibani J, Vidaud M, Duquesnoy P, et al. The peculiar spectrum of β thalassemia genes in Tunisia. Hum Genet. 1988;78(2):190-192.
18. Bouhass R, Aguercif M, Trabuchet G, Godet J. A new mutation at IVS1 nt 2(T→A), in β thalassemia from Algeria. Blood. 1990;76(5):1054-1055.
19. 0-thalassemia with a T→C substitution in the donor splice site of the first intron of the β-globin gene. Br J Haematol. 1989;71(1):113-117.
20. Lapoumeroulie C, Pagnier J, Bank A, Labie D, Krishnamoorthy R. β Thalassemia due to a novel mutation in IVS-1 sequence donor site consensus creating a restriction site. Biochem Biophy Res Commun. 1986;139(2):709-713.
21. Treisman R, Orkin SH, Maniatis T. Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes. Nature. 1983;302(5909):591-596.
22. Beldjord C, Lapoumeroulie C, Agnier J, et al. A novel β thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3′ end of IVS2. Nucleic Acids Res. 1988;16(11):4927-4935.
23. Gonzalez-Redondo JM, Stoming TA, Lanclos KD, et al. Clinical and genetic heterogeneity in Black patients with homozygous β-thalassemia from the Southeastern United States. Blood. 1988;72(3):1007-1014.
24. Gonzalez-Redondo JM, Stoming TA, Kutlar A, et al. A C→T substitution at nt -101 in a conserved DNA sequence of the promoter region of the β-globin gene is associated with 'silent' β-thalassemia. Blood. 1989;73(6):1705-1711.
25. Faustino P, Osorio-Almeida L, Barbot J, et al. Novel promoter and splice junction defects add to the genetic, clinical or geographic heterogeneity of β thalassemia in the Portuguese population. Hum Genet. 1992;89(5):573-576.
26. Orkin SH, Goff SC. Nonsense and frameshift mutations in β-thalassemia detected in cloned β-globin genes. J Biol Chem. 1981;256(19):9782-9784.
27. Atweth GF, Wong C, Reed R, et al. A new mutation in IVS1-1 of the human β globin gene causing β thalassemia due to abnormal splicing. Blood. 1987;70(1):147-151.
28. Wong C, Antonarakis SE, Goff SC, et al. β-Thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the β globin gene. Blood. 1989;73(4):914-918.
29. 2 in patients with different β-thalassemia mutations and a δ chain variant. Blood. 1990;76(6):1246-1249.
30. 0-thalassemic gene causes abnormal RNA splicing. Cell. 1982;29(3):903-911.
31. +-thalassaemia. Br J Haematol. 1990;75(1):122-126.
32. Diaz-Chico JC, Yang KG, Stoming TA, et al. Mild and severe β-thalassemia among homozygotes from Turkey: identification of the types by hybridization of amplified DNA with synthetic probes. Blood. 1988;71(1):248-251.
33. Maragoudaki E, Kanavakis E, Traeger-Synodinos J, Vrettou C, Tzettis M. Molecular, haematological and clinical studies of the -101 C→T substitution of the β-globin gene promoter in 25 β-thalassaemia intermedia patients and 45 heterozygotes. Br J Haematol. 1999;107(4):699-706.
34. Eigel A, Schnee J, Oehme R, Horst J. Mutation analysis of β-thalassemia genes in a German family reveals a rare transversion in the first intron. Hum Genet. 1989;81(4):371-372.
35. Bibi A, Messaoud T, Beldjord C, Fattoum S. Detection of two rare β-thalassemia alleles found in the Tunisian population: Codon 47 (+A) and codons 106/107 (+G). Hemoglobin. 2006;30(4):437-447.
36. Piratsu M, Saglio G, Camaschella C, et al. Delineation of specific β-thalassemia mutations in high-risk areas of Italy: A prerequisite for prenatal diagnosis. Blood. 1988;71(4):983-988.
37. Chehab FF, Der Kaloustian V, Khouri FP, Deeb SS, Kan YW. The molecular basis of β-thalassemia in Lebanon: Application to prenatal diagnosis. Blood. 1987;69(4):1141-1145.
38. Heusterspreute M, Derclaye I, Gala JC, et al. β-Thalassaemia in indigenous Belgian families: Identification of a novel mutation. Hum Genet. 1996;98(1):77-79.
39. Lemsaddek W, Picanço I, Seuanes F, et al. The β-thalassemia mutation/haplotype distribution in the Moroccan population. Hemoglobin. 2004;28(1):25-37.
40. Makhoul NJ, Wells RS, Kaspar H, et al. Genetic heterogeneity of β thalassemia in Lebanon reflects historic and recent population migration. Ann Hum Genet. 2005;69(1):55-66.
41. Dimovski A, Efremov DG, Jankovic L, et al. β-Thalassemia in Yugoslavia. Hemoglobin. 1990;14(1):15-24.
42. Petkov GH, Efremov GD, Efremov DG, et al. β-Thalassemia in Bulgaria. Hemoglobin. 1990;14(1):25-33.
43. Boussiou M, Karababa P, Sinopoulou K, Tsaftaridis P, Plata E, Loutradi-Anagnostou A. The molecular heterogeneity of β-thalassemia in Greece. Blood Cells Mol Dis. 2008;40(3):311-319.
44. Beldjord C, Lapoumeroulie C, Baird ML, et al. Four new haplotypes observed in Algerian β thalassemia patients. Hum Genet. 1983;65(2):204-206.
45. Ragusa A, Amata S, Lombardo T, et al. Asymptomatic and mild β-thalassemia in homozygotes and compound heterozygotes for the IVS2+1G→A mutation: Role of the β-globin gene haplotype. Haematologica. 2003;88(10):1099-1105.
46. Rosatelli MC, Tuveri T, Scalas MT, et al. Molecular screening and fetal diagnosis of β-thalassemia in the Italian population. Hum Genet. 1992;89(6):585-589.
47. Rosatelli MC, Dozy A, Faà V, et al. Molecular characterization of β-thalassemia in the Sardinian population. Am J Hum Genet. 1992;50(2):422-426.
48. Villegas A, Ropero P, Gonzalez FA, Anguita E, Espinos D. The thalassemia syndromes: Molecular characterization in the Spanish population. Hemoglobin. 2001;25(3):273-283.
49. Fattoum S, Messaoud T, Bibi A. Molecular basis of β-thalassemia in the population of Tunisia. Hemoglobin. 2004;28(3):177-187.
50. Chouk I, Ben Daoud B, Mellouli F, et al. Contribution to the description of the β-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin. 2004;28(3):189-195.
51. Tadmouri GO, Tüzmen S, Özcelik H, et al. Molecular and population genetic analyses of β-thalassemia in Turkey. Am J Hematol. 1998;57(3):215-220.
52. Kattamis C, Hu H, Cheng G, et al. Molecular characterization of β-thalassaemia in 174 Greek patients with thalassaemia major. Br J Haematol. 1990;74(3):342-346.
53. Agouti I, Badens C, Abouyoub A, et al. Genotypic correlation between six common β-thalassemia mutations and the XmnI polymorphism in the Moroccan population. Hemoglobin. 2007;31(2):141-149.
54. Perrin P, Bouhassa R, Mselli L, et al. Diversity of sequence haplotypes associated with β-thalassaemia mutations in Algeria: Implications for their origin. Gene. 1998;213(1-2):169-177.
55. Rouabhi F, Lapouméroulie C, Amselem S, et al. DNA haplotype distribution in Algerian β thalassaemia patients. An extended evaluation of family studies and representative molecular characterization. Hum Genet. 1988;79(4):373-376.
56. Pacheco P, Loureiro P, Faustino P, Lavinha J. Haplotypic heterogeneity of β-thalassaemia IVS1-1 (G→A) mutation in Southern Portugal. Br J Haematol. 1996;94(4):767-769.
57. Ribeiro ML, Gonçalves P, Cunha E, et al. Genetic heterogeneity of β-thalassemia in populations of the Iberian Peninsula. Hemoglobin. 1997;21(3):261-269.
58. El-Gawhary S, El-Shafie S, Niazi M, Aziz M, El-Beshlawry A. Study of β-thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian thalassemia patients. Hemoglobin. 2007;31(1):63-69.
59. Lin LI, Lin KS,Lin KH, Chang HC. The spectrum of β thalassemia mutations in Taiwan: identification of a novel frameshift mutation. Am J Hum Genet. 1991;48(4):809-812.
60. Chiou SS, Chang TT, Chen PH, Lee SL, Chen TS, Chang JG. Molecular basis and haematological characterization of β-thalassemia major in Taiwan, with a mutation of IVS1 3′ end TAG→GAG in a Chinese patient. Br J Haematol. 1993;83(1):112-117.
61. +-thalassaemia: Mutations and haematology. Br J Haematol. 2000;108(2):290-294.
62. Li WJ, Lao XW, Jai SQ, et al. A rare transcription mutation (-90C > T) in a Chinese family with β-thalassemia. Zonghua Yie Xue Yi Chuan Xue Za Zhi. 2003;20(6):468-470.
63. Gorakshakar AC, Das MK, Phanasgaokar SP, Nadkarni AH, Colah RB, Mohanty D. Origin of the codon 47 (+A) β-thalassaemia mutation among the Nicobarese of the Andaman and Nicobar islands in India. Br J Haematol. 2007;139(2):344-346.
64. Gγ de la globine. Relation avec l?expression de l?hémoglobine foetale dans les β thalassémies. Thèse de Magister (1994) USTHB Algiers, Algeria.
65. Driscoll MC, Dobkin C, Alter BP. γδbeta; Thalassemia due to a de novo mutation deleting the 5′ β-globin gene activation-region hypersensitive sites. Proc Natl Acad Sci USA. 1989;86(19):7470-7474.
66. Viprakasit V, Gibbons RJ, Broughton BC, et al. Mutations in the general transcription factor TFIIH result in β thalassemia in individuals with trichothiodystrophy. Hum Mol Genet. 2001;10(24):2797-2802.
67. Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2000;100(6):2040-2045.
68. Basset P, Braconnier F, Rosa J. An update on electrophoretic and chromatographic methods in the diagnosis of hemoglobinopathies. J Chromatogr. 1982;227(2):267-304.